Related Experiment Videos
Neuroblastoma: the challenge and frustration
1University of California at Los Angeles School of Medicine.
Hematology/Oncology Clinics of North America
|December 1, 1987
Summary
Neuroblastoma, a rare childhood cancer, presents diagnostic and therapeutic challenges. Ongoing research aims to improve treatment strategies and outcomes for affected children.
Area of Science:
- Pediatric Oncology
- Cancer Biology
- Tumorigenesis
Background:
- Neuroblastoma affects approximately 500 children annually in the US.
- Advances in tumor biology and biochemical markers aid outcome prediction.
- Current therapeutic strategies for neuroblastoma remain largely ineffective.
Purpose of the Study:
- To review the current understanding of neuroblastoma.
- To highlight challenges in developing effective therapies.
- To emphasize the need for standardized staging and further research.
Main Methods:
- Review of recent findings in neuroblastoma tumor biology.
- Evaluation of biochemical markers for outcome prediction.
- Discussion of current therapeutic approaches and their limitations.
Main Results:
- Despite advances, successful neuroblastoma therapy has not been achieved.
- Standardization of staging across centers is crucial for comparing treatment results.
- The efficacy of autologous bone marrow transplantation is yet to be determined.
Conclusions:
- Neuroblastoma continues to pose significant challenges in pediatric oncology.
- Further scientific inquiry is essential to develop novel and curative therapies.
- The ultimate goal is to provide all children with neuroblastoma a chance for a cure.